Trump has treated executive clemency as a recurring tool in his second term, issuing more than 1,700 grants by early June 2026, including a July 3 batch of 17 pardons and earlier actions covering January 6 defendants, election-related cases, and allies. The short window remaining until July 31, combined with the administration’s shifting focus toward legislative priorities and legal challenges to certain clemency practices, keeps the near-term outlook balanced. Trader pricing reflects this uncertainty: consistent past activity supports a modest edge for additional grants, while the absence of announced plans for the immediate weeks ahead and procedural pauses observed in similar periods introduce downside risk. Scheduled White House announcements or fresh clemency lists before month-end would likely shift sentiment, as would any extended quiet period without new action.